A61K 33 - Medicinal preparations containing inorganic active ingredients

Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
12/2002
12/05/2002	US20020182239 Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting
12/05/2002	US20020182167 Boric acid and a suitable carrier( such as a petroleum jelly) as an analgesic formulation can be used to provide pain relief to a person suffering from arthritis and any general pain associated with muscles or joints
12/05/2002	CA2448528A1 Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
12/04/2002	WO2001093910A2 Method for increasing the antioxidative potential of selenium-containing aqueous solutions
12/04/2002	EP1261356A2 Farnesyl protein transferase inhibitor combinations with platinum compounds
12/04/2002	EP1261335A1 Brain, spinal and nerve injury treatment
12/04/2002	EP1056438B1 Oral care compositions comprising chlorite and methods
12/04/2002	EP0814756B1 Method for preparing a preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders
12/04/2002	CN1383383A Oxygen-contg. ophthalmic compsn.
12/04/2002	CN1383381A Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives
12/04/2002	CN1095380C Medicine for treating primary menalgia
12/04/2002	CN1095378C Multifunctional calcium tablet and its prodn. process
12/04/2002	CN1095377C Medicine for treating skin ringworm and dermatitis and prepn. process
12/04/2002	CN1095375C Medicated cosmetics capable of treating primary and secondary varicose vein simultaneously and its prepn. method
12/03/2002	US6489346 Substituted benzimidazole dosage forms and method of using same
12/03/2002	US6489317 An ansamycin, at least one second antimicrobial agent selected from amoxycillin, tetracycline and bismuth compounds, and a proton pump inhibitor
12/03/2002	US6489301 Solid pharmaceutical preparation for dialysis and a process for producing the same
12/03/2002	US6488966 Administering a dose of elemental calcium that is effective to reduce carcinogenesis
12/03/2002	US6488965 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
12/03/2002	US6488956 B vitamins, iron and zinc
12/03/2002	US6488943 Anionic surfactant; proton donating agent comprising 2-pyrrolidone-5 carboxylic acid
12/03/2002	US6488665 Antimicrobial alcohol gel pre-operative skin-preparation delivery system
12/03/2002	CA2206837C Use of strontium salts to obtain pharmaceutical compositions intented for the treatment of arthrosis
11/2002
11/28/2002	WO2002094745A2 Non-peptidic cyclophilin binding compounds and their use
11/28/2002	WO2002094377A2 Pharmaceutical preparation comprising physiologically acceptable potassium and magnesium salts and use thereof for the prophylaxis and treatment of qt-interval extension
11/28/2002	WO2002094297A1 Herbal composition for the treatment of drug addiction and insomnia
11/28/2002	WO2002094294A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation
11/28/2002	WO2002094293A1 Method for the destruction of oocysts
11/28/2002	WO2002094271A1 Targeted delivery of bioaffecting compounds for the treatment of cancer
11/28/2002	WO2002094204A1 Dental restorative materials
11/28/2002	WO2002094179A2 Novel topical microbicidal compositions
11/28/2002	WO2002094021A1 A combination and method of treatment of cancer utilizing a cox-2 inhibitor and an hmg-coa inhibitor and cystine to enhance glutathione
11/28/2002	WO2002078616A3 Methods for increasing serotonin levels by administering (-)-hydroxycitric acid
11/28/2002	WO2001089542A3 Composition for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant
11/28/2002	US20020177624 Prevents vaginitis
11/28/2002	US20020177585 Peroxidation reaction products of an alkene, such as geraniol; penetrating solvent, such as dimithyl sulfoxide; a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone.
11/28/2002	US20020176911 Includes xanthan gum which improves tolerance (e.g. less gastrointestinal symptoms such as emesis, stool patterns and gas)
11/28/2002	US20020176887 Methods of delivery of cetyl myristoleate
11/28/2002	US20020176885 Given concentration of halide-comprising salts such as sodium chloride; nonirritating antiseptic; can be used in eyes
11/28/2002	US20020176883 Effects of dietary cation-anion difference (DCAD) and essential fatty acid nutrients on calcium homeostasis in prepartum dairy cattle (hypocalcemia)
11/28/2002	US20020176843 Polyamide particles as anti-irritant agents
11/28/2002	US20020176840 A porous spherical carbonaceous substance has a diameter 0.01 to 1 mm, and a specific surface area, excellent adsorbability of harmful toxins in gastrointestinal tracts; treating patients with liver or renal diseases
11/28/2002	US20020176827 Carrier and composition comprising polybutene with molecular weight of 300-3000 and one or more cosmetic or therapeutic actives, releasably associated to carrier
11/28/2002	DE10109303A1 Compositions comprising at least one mineral salt and (R)-alpha-lipoic acid or (S)-alpha-lipoic acid are useful as food supplements, in cosmetic formulations or for the production of medicines
11/28/2002	CA2447608A1 Method for the destruction of oocysts
11/27/2002	EP1260226A1 Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders
11/27/2002	EP1260210A1 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
11/27/2002	EP1259282A1 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
11/27/2002	EP1259237A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
11/27/2002	EP1259234A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
11/27/2002	EP1259224A2 Cochleate formulations and their use for delivering biologically relevant molecules
11/27/2002	EP1259114A1 A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
11/27/2002	EP1259112A1 Nutritional intervention composition for enhancing and extending satiety
11/27/2002	EP1107795B1 Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis
11/27/2002	EP0910360B1 Reduction of cardiotoxicity of an antitumor agent using manganese compound
11/27/2002	CN1382206A Color safe laundry methods employing zwitterionic formulation components
11/27/2002	CN1382050A Oral formulations for anti-tumor compounds
11/27/2002	CN1381512A Multi-arm fork type functional polyethylene glycol preparation method and its application in medicine
11/27/2002	CN1381263A Weight-lossing hypolipemic medicine
11/27/2002	CN1381257A Chinese-medicinal antihypertensive pillow
11/27/2002	CN1381255A Compoiste bear gall spray for treating rhinocleisis and its preparing process
11/27/2002	CN1381252A Chines medicine for treating silicosis
11/27/2002	CN1381238A Injection for treating pile and fistula and its preparing process
11/26/2002	US6486179 Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
11/26/2002	US6486138 Ophthalmic compositions containing galactomannan polymers and borate
11/26/2002	US6486122 Methods of increasing body weight in a subject by administering TGF-α
11/26/2002	US6485758 Charcoal, vitamin b6, ma huang (herb containing ephedrine) and inert, nontoxic carrier
11/26/2002	US6485755 Methods of using electron active compounds for managing cancer
11/26/2002	CA2355247C Method for the prevention and treatment of cachexia and anorexia
11/21/2002	WO2002092617A1 Combined approach to treatment of cancer using a c-myc antisense oligomer
11/21/2002	WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002	WO2002092126A1 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer
11/21/2002	WO2002092083A1 7,8-fused 4$i(h)-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002	WO2002092075A2 Therapeutic delivery of carbon monoxide
11/21/2002	WO2002092055A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents
11/21/2002	WO2002092045A1 Cosmetic composition based on zinc and copper sulphates and sucralphate
11/21/2002	WO2002092042A2 Pharmaceutical and cosmetic compositions against skin aging
11/21/2002	WO2002091833A1 Prebiotic and probiotic compositions and methods for their use in gut-based therapies
11/21/2002	WO2002067953A3 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia
11/21/2002	WO2002063308A3 Prediction of wound healing by urinary nitrate assay
11/21/2002	WO2002036171A9 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
11/21/2002	US20020173510 Nutrient mixture; fatty acid, calcium compound and vitamins
11/21/2002	US20020172728 Administering to the woman an effective amount of an herbal extract wherein an active ingredient in herbal extract is galanthamine for improving estrogen-deficiency related neurodegeneration and cognitive dysfunction
11/21/2002	US20020172727 Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
11/21/2002	US20020172724 Administering a beverage composition suitable for human consumption comprising effective amounts of the following solubilized components: calcium compound, acid, inulin to reduce the risk of bone density loss
11/21/2002	US20020172722 For therapy and in cosmetics
11/21/2002	US20020172719 Pharmaceutical compositions and methods for managing skin conditions
11/21/2002	US20020172645 Administering aerosolized thiocyanate for therapy of lung infection in a primate suffering from cystic fibrosis
11/21/2002	CA2447574A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents
11/21/2002	CA2447275A1 Therapeutic delivery of carbon monoxide
11/21/2002	CA2447052A1 Combined approach to treatment of cancer using a c-myc antisense oligomer
11/21/2002	CA2446956A1 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer
11/20/2002	EP1258248A2 Tumor treatments comprising a fumagillol derivative and a further antineoplastic agent
11/20/2002	EP1107732B1 Oral liquid mucoadhesive compositions
11/20/2002	EP1033984B1 Concentrate for medical solution and use thereof
11/20/2002	EP0813424B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
11/20/2002	CN1380092A Zhiyusan powder for curing hemorrhoid
11/20/2002	CN1380065A Trace element preparation for livestock and fowl and its preparation method
11/20/2002	CN1094368C Chinese medicine for curing alopecia
11/20/2002	CN1094355C Yuganwan pill for curing hepatiotis and ascites due to cirrhosis

1 ... 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 ... 563